Table 3.
Group | No. of Events/No. at Risk | Adjusted HR (95% CI)a | Pb |
---|---|---|---|
All patients | 93/1105 | 1.34 (1.07 to 1.68) | |
Age (yr) | |||
<30 | 23/276 | 1.31 (0.84 to 2.04) | 0.890 |
30 to 40 | 36/514 | 1.30 (0.93 to 1.81) | |
>40 | 34/222 | 1.44 (1.03 to 1.99) | |
Gender | |||
female | 30/486 | 1.65 (1.12 to 2.42) | 0.209 |
male | 63/526 | 1.23 (0.94 to 1.62) | |
Race | |||
white | 88/983 | 1.35 (1.08 to 1.70) | 0.867 |
nonwhite | 5/29 | 0.82 (0.20 to 3.45) | |
DCCT treatment group | |||
intensive | 26/554 | 1.40 (1.03 to 1.89) | 0.697 |
conventional | 67/458 | 1.29 (0.95 to 1.75) | |
HbA1c (%) | |||
<7 | 4/240 | 1.71 (0.81 to 3.63) | 0.470 |
7 to 9 | 24/527 | 1.45 (1.06 to 1.99) | |
>9 | 65/245 | 1.18 (0.88 to 1.58) | |
AER (mg/24 h) | |||
<10 | 31/598 | 1.23 (0.83 to 1.80) | 0.805 |
10 to 20 | 35/342 | 1.29 (0.93 to 1.77) | |
20 to 30 | 27/72 | 1.45 (0.99 to 2.10) |
Discrete proportional hazards model includes waist circumference (scaled to 10 cm), age, gender, race, duration of diabetes, DCCT treatment group, smoking status, HbA1c, and AER, each measured at DCCT closeout.
Tests hypothesis that HR differs among subgroups of covariate.